{
    "clinical_study": {
        "@rank": "4889", 
        "arm_group": [
            {
                "arm_group_label": "prophylactic", 
                "description": "Prophylactic treatment with drugs to prevent venous thromboembolism in patients operated with open surgery for intracranial meningioma at the Department of neurosurgery at Karolinska Hospital, Stockholm, Sweden"
            }, 
            {
                "arm_group_label": "non-prophylactic", 
                "description": "No use of prophylactic treatment with drugs to prevent venous thromboembolism in patients operated with open surgery for intracranial meningioma at the Departments of neurosurgery at University Hospital North Norway (UNN) and St.Olavs University Hospital (Troms\u00f8 and Trondheim respectively, both Norway)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to compare different strategies for prevention of venous\n      thromboembolism related to intracranial meningioma surgery. The investigators identified\n      three hospitals where two have a very restrictive approach with respect to anticoagulant\n      therapy while at the third hospital the use of anticoagulation the day before surgery was\n      initiated as routine prophylaxis.\n\n      Based on this \"natural experiment\" it will be explored whether the use of anticoagulant\n      prophylaxis is associated with reduced risk of venous thromboembolism and/or associated with\n      increased risk of postoperative hemorrhage as compared to the 2 cohorts where this\n      intervention were absent."
        }, 
        "brief_title": "A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Meningioma", 
        "condition_browse": {
            "mesh_term": [
                "Meningioma", 
                "Thromboembolism", 
                "Venous Thromboembolism", 
                "Venous Thrombosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  First included patient 1.january 2007 and latest included patient 1.july 2013 (allows\n             for 30 day follow up with respect to morbidity)\n\n          -  Histological verification of a meningioma (of any grade) from the current surgery\n\n        Exclusion Criteria:\n\n          -  Intracranial surgery or venous thromboembolism the last 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients having had surgical treatment for intracranial meningioma in Norway (St Olavs\n        University Hospital, Trondheim, and University Hospital North Norway, Troms\u00f8) and Sweden\n        (Karolinska University Hospital, Stockholm)."
            }
        }, 
        "enrollment": {
            "#text": "650", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01941602", 
            "org_study_id": "2013/884"
        }, 
        "intervention": [
            {
                "arm_group_label": "prophylactic", 
                "description": "enoxaparin had been prescribed at a dose of 40 mg (once daily) from the evening before surgery until patients were well mobilized. Also, at the time of surgery compression stockings were used, as well as a sequential compression device (SCD) until the morning after or longer if mobilization was delayed", 
                "intervention_name": "prophylactic enoxaparin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "non-prophylactic", 
                "description": "no pharmacological prophylaxis for venous thromboembolism (VTE) had been used routinely. Occasionally, with delayed mobilization, a low-dose low molecular weight heparin (LMWH) had been prescribed. SCD had been used at increased frequency, and is today considered routine.", 
                "intervention_name": "non-prophylactic", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Enoxaparin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "surgery", 
            "enoxaparin", 
            "venous thromboembolism", 
            "perioperative care"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Kristin.Sjavik@unn.no", 
                    "last_name": "Kristin Sj\u00e5vik, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Troms\u00f8", 
                        "country": "Norway"
                    }, 
                    "name": "University Hospital of North Norway"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "asgeir.s.jakola@stolav.no", 
                    "last_name": "Asgeir S Jakola, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Trondheim", 
                        "country": "Norway"
                    }, 
                    "name": "St Olavs Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "petter.forander@karolinska.se", 
                    "last_name": "Petter F\u00f6rander, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Karolinska University Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Norway", 
                "Sweden"
            ]
        }, 
        "number_of_groups": "2", 
        "official_title": "A Comparative Study of Prophylactic Enoxaparin Routinely Administered Preoperative for Prevention of Venous Thromboembolism in Meningioma Surgery - an Acceptable Risk-benefit Ratio?", 
        "overall_contact": {
            "email": "asgeir.s.jakola@ntnu.no", 
            "last_name": "Asgeir S Jakola, MD PhD"
        }, 
        "overall_contact_backup": {
            "email": "ole.solheim@ntnu.no", 
            "last_name": "Ole Solheim, MD PhD"
        }, 
        "overall_official": {
            "affiliation": "St. Olavs Hospital", 
            "last_name": "Asgeir S Jakola, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "frequencies of venous thromboembolism", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01941602"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "frequencies of hematomas in need of reoperation or that significantly alters subsequent care (e.g. intensive care unit or other intensified treatment based on postoperative intracranial hemorrhage)", 
            "measure": "frequencies of hematomas in need of reoperation or that significantly alters subsequent care", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "source": "St. Olavs Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Norwegian University of Science and Technology", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital of North Norway", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Karolinska University Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "St. Olavs Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}